Kyle Malady - May 20, 2022 Form 4 Insider Report for DEXCOM INC (DXCM)

Role
Director
Signature
By: Jereme Sylvain For: Kyle Malady
Stock symbol
DXCM
Transactions as of
May 20, 2022
Transactions value $
$1
Form type
4
Date filed
5/23/2022, 05:06 PM
Previous filing
May 16, 2022
Next filing
May 31, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Award $0.98 +979 +44.87% $0.00* 3.16K May 20, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The RSU Award was granted on May 20, 2022 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2023 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.
F2 Included in this number are 1,827 unvested restricted stock units, 979 of which were granted on May 20, 2022 and shall vest on the earlier of the one year anniversary of the grant or the date of DexCom Inc's 2023 Annual Meeting and 848 of which were granted on October 11, 2020 and shall vest through October 11, 2023.